Adjutor Healthcare is a leading healthcare services company operating globally.
No matter what your stage of product development or lifecycle, we can provide an experienced, tailored team to support your business objectives.

Strategy and Project Management
Strategy is key to everything we do. We will design a focused plan of how to achieve your commercial product vision.

Development and Clinical
We are specialists in drug and device development requirements, including lab, non-clinical and clinical, as well as acting as a CRO.

Regulatory Affairs and Market Access
Adjutor are experts in regulatory affairs and market access, able to guide you to market efficiently and effectively.

Sponsorship and Commercialisation
We can help you to access a wide variety of countries and ensure effective commercialisation and product launch strategies.

Quality and Training
We provide QMS system design & implementation that is fit for your purposes, training of staff in the QMS together with a variety of auditing solutions.
Risk Management
RMP development, writing and review of technical protocols and reports.
Registration Pathways
Orbis / ACCESS / Orphan / Provisional / Priority and other expedited pathways.
QMS System Design
Comprehensive audits covering GMP / GLP / GCP / GDP / ISO9001 / ISO13485.
Data Analytics
Understanding and managing your data and biostatistics.
Why Choose Us?
We get SMEs and the Adjutor Advantage is how we demonstrate, every day, that we are a great partner for your business. We’re engaged, and motivated, to help you at each stage of your journey to market and beyond.
Learn More About Us
We’re a company of down to earth, like-minded, individuals who are enthusiastic and engaged, with a love of life and learning. We work in a collegial way to support each other and our clients.
Latest Insights
Insights • Articles • Latest News • Regulatory Announcements
Stay up to date with industry developments in Australia/New Zealand and beyond.
Life Sciences Expansion Strategies Greater Bay Area – China
China’s Greater Bay Area (GBA) initiative aims to create a single, integrated economic zone, fostering innovation, connectivity, and environmental sustainability. We explore how the Greater Bay Area (GBA) is transforming life sciences and medical device access in China, with regulatory benefits and streamlined market entry opportunities. What is the Greater Bay Area (GBA)? The Greater…
Australia’s TGA Priority Review Pathway
How Australia’s TGA Priority Review Pathway Helps Speed Up Access to New Medicines. The ultimate goal of every regulatory submission is patient access. Whether seeking approval for a new prescription medicine or an additional indication for an existing drug, the objective remains the same — providing patients with the best possible treatment options as quickly…
Medsafe Rule of 2 Verification Pathway
Medsafe Rule of 2 Verification Pathway= Faster access to medicines The proposed Verification Pathway aims to accelerate market access for certain medicines by enabling Medsafe approval within 30 days, provided they’ve already been approved in two recognised overseas jurisdictions. This initiative is part of the Medicines Amendment Bill, now open for public consultation until 19…
Ready for growth?
Contact us today and let’s work together to achieve your goals. Whether you have a question, need more information, or want to discuss your project, our team is here to help.